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Open access under the ElChagas disease is caused by Trypanosoma cruzi, being considered a public health problem. An alternative
to combat this pathogen is the use of natural products isolated from fruits such as Eugenia uniﬂora, a plant
used by traditional communities as food and medicine due to its antimicrobial and biological activities.
Ethanolic extract from E. uniﬂora was used to evaluate in vitro anti-epimastigote and cytotoxic activity.
This is the ﬁrst record of anti-Trypanosoma activity of E. uniﬂora, demonstrating that a concentration pre-
senting 50% of activity (EC50) was 62.76 lg/mL. Minimum inhibitory concentration (MIC) was 61024 lg/
mL. Our results indicate that E. uniﬂora could be a source of plant-derived natural products with anti-epi-
mastigote activity with low toxicity.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Developing countries with traditional use of the biodiversity as
medicine, including Brazil, still suffer with the so-called ‘‘neglected
diseases’’ (Funari and Ferro, 2005), which are treated by traditional
communities with plant natural products. Brazil features the larg-
est biodiversity in the world (Elisabetsky and Costa-Campos,
1996); however only 8% have been studied in search for bioactive
compounds (Garcia et al., 1996).
Chagas disease, caused by Trypanosoma cruzi, affects about 18
million people in the Americas (Reyes-Chilpa et al., 2008). This par-
asite can be transmitted to humans by triatomine insects, foods,
blood and organs from infected donors, or by transplacental con-
tamination (WHO, 2010). Currently, the chemotherapy of this dis-
ease consists mainly of nifurtimox and benzonidazole (WHO,
2010), which show a cure rate of 70–50% in the acute phase and
less than 20% in the chronic phase (Dias and Dessoy, 2009). Several
studies involving the analysis of natural plant products havee Microbiologia e Biologia
lógica – DQB, Universidade
1, Pimenta 63105-000, Crato
Coutinho).
sevier OA license.recommended them as alternative sources of drugs against T. cruzi,
including Arrabidaea triplinervia (Leite et al., 2006), Dracocephalum
kotschyi (Saeidnia et al., 2004) and Azorella compacta (Araya et al.,
2003).
The effects of all natural products can be limited by their tox-
icity. Evaluating the toxicity of active substances is one of the
most important steps for the utilization of these compounds in
animal models. The drugs currently utilized against Chagas dis-
ease feature high toxicity, affecting host tissues (Dias and Dessoy,
2009).
Eugenia uniﬂora is often used as food and medicine in folk med-
icine due to antimicrobial (Holetz et al., 2002) and other biological
activities (Sharma et al., 2006). Known in Brazil as pitanga, this
plant has been studied due to its antioxidant (Velazquez et al.,
2003), hypotensive (Consolini and Sarubbio, 2002), photosensitiz-
ing and antibiotic modulatory (Coutinho et al., 2010a,b) activities.
Several phytoconstituents of E. uniﬂora have been isolated, such as
ﬂavonoids myricitrin, quercetin and quercitrin 3-ramnoside, as
well as steroids, mono- and triterpenoid compounds, tannins,
anthraquinones, phenols, cineol and essential oils (Bandoni et al.,
1972; Wazlawik et al., 1997).
Thus, due to the social and economic importance of Chagas dis-
ease as neglected diseases and the medicinal use of this fruit in
ethnomedicine, this work evaluated the anti-Trypanosoma and
cytotoxic activities of E. uniﬂora.
Table 1
Percent parasite lysis induced by extracts of Eugenia uniﬂora against the epimastigote
form of Trypanosoma cruzi CL-B5 strain.
Extract Concentrations
(lg/mL)
%AE %SD %C EC50
EEEU 100 80.83 0.1 8
10 64.80 3.6 0 62.76
1 27.29 7.3 0
Nifurtimox 10 89.1 3.3 –
1 54.9 0.7 – 0.91
0.5 45.6 4.2 –
%AE – percentual of antiepimastigote activity; %SD – standard deviation; %C –
cytotoxic percentual; EC50 – concentration that present 50% of effect.
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2.1. Plant material
Leaves of E. uniﬂora were collected during the rainy season
(April, 2008) in the municipality of Crato, Ceará State, Brazil. The
plant material was identiﬁed by Dr. Arlene Pessoa, and a voucher
specimen was deposited with identiﬁcation number #3106 at the
‘‘Dárdano de Andrade Lima’’ Herbarium of Universidade Regional
do Cariri – URCA.
2.2. Preparation of E. uniﬂora ethanol extract (EEEU)
A total of 200 g of leaves were dried and powdered at room
temperature. The powdered material was extracted by maceration
using 1 L of 95% ethanol as solvent at room temperature. The mix-
ture was allowed to stand for 72 h at room temperature. The ex-
tract was then ﬁltered and concentrated under vacuum in a
rotary evaporator (60 C and 760 mm/Hg of temperature and pres-
sure) (Brasileiro et al., 2006). Each 200 g of aerial parts yield 5.6 g
of extract. The EEEU was diluted using DMSO.
2.3. Cell strains
For in vitro studies of anti-Trypanosoma activity, epimastigote
clone CL-B5 was used (Buckner et al., 1996). The parasites transfec-
ted with the Escherichia coli b-galactosidase gene (lacZ), were
kindly provided by Dr. F. Buckner through Instituto Conmemora-
tivo Gorgas (Panama). The epimastigotes were cultivated at 28 C
in Liver Infusion Tryptose Broth (Difco, Detroit, MI), supplemented
with 10% fetal bovine serum (FBS) (Gibco, Carlsbad, CA), penicillin
(Ern, S.A., Barcelona, Spain) and streptomycin (Reig Jofré S.A.,
Barcelona, Spain), as described by Le Senne et al. (2002). Cells were
harvested during the exponential growth phase. Murine J774 mac-
rophages were used to evaluate the cytotoxic potential of the ex-
tract. This cell strain was grown in plastic 25 lL ﬂasks with RPMI
1640 medium (Sigma) supplemented with 20% fetal bovine serum
(FBS), heat inactivated (30 min, 56 C), penicillin G (100 U/mL) and
streptomycin (100 lg/mL) in a humidiﬁed, with 5% CO2/95% air
atmosphere at 37 C. For the assay, cells in the pre-conﬂuence
phase were harvested with trypsin and kept at 37 C in a humidi-
ﬁed 5% CO2 atmosphere. The cell viability measurement was a col-
orimetric method using resazurin as described by Rolón et al.
(2006).
2.4. Reagents
Resazurin sodium salt was obtained from Sigma–Aldrich (St.
Louis, MO, USA) and stored at 4 C protected from light. The resa-
zurin solution was prepared using 1% phosphate buffered solution
(PBS), pH 7, and sterilized by ﬁltration prior to use. Chlorophenol
red-b-D-galactopyranoside (CPRG; Roche, Indianapolis, IN, USA)
was dissolved in 0.9% Triton X – 100 (pH 7.4). The solutions of anti-
biotics penicillin G (Ern, S.A., Barcelona, Spain), streptomycin (Reig
Jofré S.A., Barcelona, Spain) were prepared following the recom-
mendations of the National Committee for Clinical Laboratory
Standards – NCCLS (NCCLS, 2003).
2.5. Epimastigote susceptibility assay
The screening assay was performed in 96-well microplates with
cultures that had not reached the stationary phase, as described by
Vega et al. (2005). Brieﬂy, epimastigotes were seeded at
1  105 mL1 in 200 lL of Liver Tryptose Broth medium. The plates
were incubated with the drugs in concentrations ranging between0.1 and 50 lg/mL, at 28 C for 72 h, at which time 50 lL of CPRG
solution was added to reach a ﬁnal concentration of 200 lM. The
plates were incubated at 37 C for 6 h and were evaluated using
a spectrophotometer at 595 nm. Nifurtimox was used as the refer-
ence drug. Each concentration was tested in triplicate. Each exper-
iment was performed twice separately. The efﬁcacy of each
compound was estimated by calculating the anti-epimastigote per-
centage (AE%) (Table 1).
2.6. Cytotoxicity assays
J774 macrophages were seeded (5  104 cells/well) in 96-well
ﬂat-bottom microplates with 100 lL of RPMI 1640 medium. The
cells were allowed to attach for 24 h in a humidiﬁed, with 5%
CO2/95% air atmosphere at 37 C. The medium was replaced by
200 lL of medium with different concentrations of the drugs and
exposed for another 24 h. Growth controls were also included.
Next, 20 lL of resazurin solution with 2 mM were added and the
plates were returned to the incubator for another 3 h. Resazurin
reduction was determined by dual wavelength absorbance mea-
surements at 490 and 595 nm, respectively. Each concentration
was assayed three times. Medium and drug controls were used
in each test. The cytotoxicity of each compound was estimated
by calculating the cytotoxic percentage (C%) (Table 1).
2.7. Statistical analysis
The EC50 values (concentration of extract needed to necessary
for produce of 50% maximal effect) were determined by linear
regression analysis of the using Prism Software 5.0.
3. Results and discussion
3.1. Anti-epimastigote assay
The anti-epimastigote activity of EEEU is shown in Table 1. The
results showed 80% inhibition with a concentration of 100 lg/mL,
featuring EC50 = 62.76 lg/mL, which was quite impressive due the
fact that EC50 lower than 500 lg/mL is considered clinically rele-
vant (Rosas et al., 2007).
This is the ﬁrst report of anti-Trypanosoma activity for E. uniﬂ-
ora. This activity was previously reported for the family Myrtaceae.
Siphoneugena densiﬂora showed a strong effect against T. cruzi;
however, its isolated compounds did not show similar activity
(Gallo et al., 2008). Other plants of the Brazilian ﬂora have shown
substantial trypanocidal activity, such as Ampelozizyphus amazoni-
cus, a plant native to the Amazon forest, containing compounds
with potential for use as a prophylactic agent against that parasite
(Rosas et al., 2007). The ethyl acetate fraction of the aqueous ex-
tract of Camellia sinensis leaves and the principal components of
this fraction (catechins) demonstrated anti-trypo and amastigote
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ported for Dracocephalum komarovi (Saeidnia et al., 2004), Vitex tri-
folia L. (Kiuchi et al., 2004), A. triplinervia (Leite et al., 2006) and A.
compacta (Araya et al., 2003).
3.2. Cytotoxic activity
The cytotoxic activity of natural products against mammalian
cells is an important point in the search for active compounds with
biological activity. The results of cytotoxic activity of EEEU against
J774 macrophages are presented in Table 1. A low toxicity was ob-
served (8% to 100 lg/mL, and this toxicity was reduced to 0% with
a concentration of 10 lg/mL). This low toxicity associated with try-
panocidal andmodulatory activity indicates that newassays need to
be carried out in vivo to demonstrate the real potential of the EEEU
against these pathogens and its effective nutraceutical potential.
The evaluation of cytotoxic activity of natural products could be
demonstrated by the numerous reports using different cell models:
Calophyllum brasiliense, tested with human lymphocytes (Reyes-
Chilpa et al., 2008); Capparis spinosa, Kleinia odora and Psiadia
punctulata, assayed with MRC-5 cells (Abdel-Sattar et al., 2010);
and neolignans, such as licarin A and burchellin, evaluated against
peritoneal macrophages (Cabral et al., 2010). The ethanol extract of
E. uniﬂora appears to be promising in the development of more
effective therapies, mainly due to the low level of toxicity
in vitro, which allows us to proceed with in vivo studies for drug
evaluation.
4. Conclusion
Our results indicate that E. uniﬂora (and the family Myrtaceae in
general) could be a source of nutraceuticals with anti-Trypanosoma
activity, representing an interesting alternative to combat infec-
tious diseases as Chagas disease. This plant appears to be promis-
ing in the development of therapies, mainly due the low toxicity
in vitro, which allows us to proceed with in vivo studies for drug
evaluation.
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